Skip to main content
Many King County facilities are closed to the public. Learn how to access services remotely or while following social distancing guidelines.  
King County logo
February 2, 2020

Select a tab below to navigate through sections:

CDC has created a flow diagram to assist clinicians in assessing patient for 2019- nCoV (also see https://www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html). Clinicians may use the flow diagram in concert with CDC Criteria to Guide Evaluation of Persons Under Investigation (PUI) for 2019-nCoV: Patients in the United States who meet the following criteria should be evaluated as a PUI for 2019-nCoV:

  • Fever1 OR signs/symptoms of lower respiratory illness (e.g. cough or shortness of breath)

    AND

    • Any person, including health care workers, who has had close contact2 with a laboratory- confirmed3,4 2019-nCoV patient within 14 days of symptom onset

  • Fever1AND signs/symptoms of a lower respiratory illness (e.g., cough or shortness of breath)

    AND

    • A history of travel from Hubei Province, China5 within 14 days of symptom onset

  • Fever1 AND signs/symptoms of a lower respiratory illness (e.g., cough or shortness of breath) requiring hospitalization4

    AND
    • A history of travel from mainland China5 within 14 days of symptom onset

  • The criteria are intended to serve as guidance for evaluation. Patients should be evaluated and discussed with Public Health (206-296-4774) on a case-by-case basis if their clinical presentation or exposure history is equivocal (e.g., uncertain travel or exposure).

  • If a patient meets these criteria:

NOTES

1 Fever may be subjective or confirmed

2 Close contact is defined as—

1/2

  1. being within approximately 6 feet (2 meters) of a 2019-nCoV case for a prolonged period of time while not wearing recommended personal protective equipment or PPE (e.g., gowns, gloves, NIOSH-certified disposable N95 respirator, eye protection); close contact can occur while caring for, living with, visiting, or sharing a health care waiting area or room with a 2019-nCoV case – or –

  2. having direct contact with infectious secretions of a 2019-nCoV case (e.g., being coughed on) while not wearing recommended personal protective equipment.

See CDC’s updated Interim Healthcare Infection Prevention and Control Recommendations for Patients Under Investigation for 2019 Novel Coronavirus.

Data to inform the definition of close contact are limited. Considerations when assessing close contact include the duration of exposure (e.g., longer exposure time likely increases exposure risk) and the clinical symptoms of the person with 2019-nCoV (e.g., coughing likely increases exposure risk as does exposure to a severely ill patient). Special consideration should be given to those exposed in health care settings.

3 Documentation of laboratory-confirmation of 2019-nCoV may not be possible for travelers or persons caring for patients in other countries.

4 Category also includes any member of a cluster of patients with severe acute lower respiratory illness (e.g., pneumonia, ARDS) of unknown etiology in which 2019-nCoV is being considered that requires hospitalization. Such persons should be evaluated in consultation with state and local health departments regardless of travel history.

5 For persons with travel to China within 14 days that are being regularly monitored by local health departments or referred for evaluation from border screening, testing for nCoV can be considered at the discretion of the health officials for all persons with illnesses with fever and lower respiratory symptoms (those hospitalized and those not hospitalized).